Fortress Biotech Stock Analysis

Fortress Stock Analysis Notes

About 21.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.9. Some equities with similar Price to Book (P/B) outperform the market in the long run. Fortress Biotech recorded a loss per share of 0.91. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 10th of October 2023. Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. Fortress Biotech, Inc. was incorporated in 2006 and is based in Bay Harbor Island, New York. Fortress Biotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 173 people. To learn more about Fortress Biotech call Lindsay Rosenwald at 781 652 4500 or check out https://www.fortressbiotech.com.

Fortress Biotech Investment Alerts

Fortress Biotech Upcoming and Recent Events

Fortress Largest EPS Surprises

View All Earnings Estimates

Fortress Biotech Environmental, Social, and Governance (ESG) Scores

Fortress Stock Institutional Investors

Note, although Fortress Biotech's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Fortress Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 81.23 M.

Fortress Profitablity

The company has Profit Margin (PM) of (0.25) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.22) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.22.

Management Efficiency

Fortress Biotech has return on total asset (ROA) of (0.4094) % which means that it has lost $0.4094 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (7.8432) %, meaning that it created substantial loss on money invested by shareholders. Fortress Biotech's management efficiency ratios could be used to measure how well Fortress Biotech manages its routine affairs as well as how well it operates its assets and liabilities. As of the 15th of October 2025, Return On Tangible Assets is likely to drop to -0.43. In addition to that, Return On Capital Employed is likely to drop to -1.59. At this time, Fortress Biotech's Fixed Asset Turnover is very stable compared to the past year.

Technical Drivers

As of the 15th of October 2025, Fortress Biotech shows the Coefficient Of Variation of 938.67, downside deviation of 6.7, and Mean Deviation of 4.39. Fortress Biotech technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Fortress Biotech Price Movement Analysis

Fortress Biotech Insider Trading Activities

Fortress Biotech Outstanding Bonds

Fortress Biotech Predictive Daily Indicators

Fortress Biotech Forecast Models

Fortress Biotech's time-series forecasting models are one of many Fortress Biotech's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Fortress Biotech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Fortress Biotech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Fortress shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Fortress Biotech. By using and applying Fortress Stock analysis, traders can create a robust methodology for identifying Fortress entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Fortress analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Fortress analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Fortress Biotech stock analysis indicators help investors evaluate how Fortress Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Fortress Biotech shares will generate the highest return on investment. By understating and applying Fortress Biotech stock analysis, traders can identify Fortress Biotech position entry and exit signals to maximize returns.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fortress Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Fortress Stock, please use our How to Invest in Fortress Biotech guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fortress Biotech. If investors know Fortress will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fortress Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Fortress Biotech is measured differently than its book value, which is the value of Fortress that is recorded on the company's balance sheet. Investors also form their own opinion of Fortress Biotech's value that differs from its market value or its book value, called intrinsic value, which is Fortress Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fortress Biotech's market value can be influenced by many factors that don't directly affect Fortress Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Fortress Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fortress Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fortress Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.